Fourshealth-header-logo

Cardiovascular Disease

product outline right
Cardiovascular Diseases chalenge desk newer

Understanding Cardiovascular Disease (CVD)

Cardiovascular Diseases chalenge mbl new

Cardiovascular disease (CVD) refers to a group of conditions that affect the heart and blood vessels, primarily caused by the accumulation of fatty deposits in the arteries—a process known as atherosclerosis. This condition can lead to serious complications, including heart attacks and strokes.

Globally, cardiovascular diseases (CVDs) remain the leading cause of death, responsible for approximately 20.5 million deaths in 2021. Heart attacks and strokes account for most acute cases, with ischemic heart disease as the primary contributor. While age-standardized death rates from CVDs have declined globally since 1990, the absolute number of deaths continues to rise, especially in low- and middle-income countries

Specific conditions under CVD include:

Coronary Heart Disease

Coronary Heart Disease

Cerebrovascular Disease

Cerebrovascular Disease

Peripheral Arterial Disease

Peripheral Arterial Disease

Rheumatic Heart Disease

Rheumatic Heart Disease

Aortic Disease

Aortic Disease

Early detection plays a critical role in reducing mortality and improving patient outcomes, yet conventional methods may not always capture early vascular changes.

Challenges in Detecting Cardiovascular Disease

Accurate detection of CVD is complex due to the systemic nature of the disease and the need for advanced diagnostic tools. Some of the primary challenges include

Retinal Images and CVD new

Challenges in Detecting Cardiovascular Disease

Retinal Images and CVD new mbl

Accurate detection of CVD is complex due to the systemic nature of the disease and the need for advanced diagnostic tools. Some of the primary challenges include

FH-POISE and Cardiovascular Disease Detection

Our advanced AI platform, FH-POISE, enhances cardiovascular disease detection through retinal imaging. It leverages the retina’s microvasculature as a window to systemic health, enabling non-invasive identification of cardiovascular risk factors.

How FH-POISE Supports Cardiovascular Disease Detection:

Integrated Image Insights

Integrated Image Insights

Analyzes retinal blood vessels to detect key indicators such as vessel caliber changes, microaneurysms, and vascular abnormalities linked to CVD.

Comprehensive Reporting

Comprehensive Reporting

Provides detailed, AI-generated reports that give clinicians deeper insights into cardiovascular risks through retinal biomarkers.

Early Intervention

Early and Accurate Detection

Identifies early-stage vascular changes that may indicate underlying cardiovascular conditions, facilitating timely intervention.

Advanced Biomarker Identification

Advanced Biomarker Identification

Detects subtle patterns and structural changes in retinal images to reveal signs of systemic vascular health issues.

By integrating retinal imaging with deep learning algorithms, FH-POISE enables faster, more accurate detection of cardiovascular risks. This supports proactive clinical decision-making and improves patient outcomes through early intervention and personalized care.

product-outline-left

CVD AI Work Flow

cvd worflow desktop chart newer
cvd worflow mobile chart new